Silica-coated solid lipid nanoparticles enhance antioxidant and antiradical effects of meloxicam

다국어 초록 (Multilingual Abstract)

Oxidative stress and decreased antioxidant status are the hallmarks in patients suffering from rheumatoid arthritis. A targeted nanocarrier can enhance the therapeutic efficacy of meloxicam, a preferential cyclooxygenase-2 inhibitor with potential suppressive effects on free-radical mediated damage. Silica-coated solid lipid nanoparticles of meloxicam were fabricated by melt emulsification ultrasound homogenization technique and characterized for formation, morphology, morphometrical properties, drug entrapment, drug release pattern and storage stability. The in vitro antioxidant potential of lipid nanoparticles was evaluated by various antiradical and antioxidant assays including 1,1-diphenyl-2-picryl-hydrazil free radical scavenging, nitric oxide radical inhibition, lipid peroxidation, hydroxyl radical scavenging and superoxide anion radical scavenging activity. Lipid nanoparticles were successfully characterized for morphometrical parameters by photon correlation spectroscopy measurements. Transmission electron microscopy and atomic force microscopy studies confirmed the production of lipid nanoparticles.
Meloxicam was successfully encapsulated within the lipid matrix as indicated by high drug entrapment efficiency,Fourier transform infrared spectroscopy and powder X-ray diffraction studies. The drug release from lipid nanoparticles exhibited a biphasic release pattern with good storage stability. Free radical scavenging activity of silica-coated meloxicam loaded solid lipid nanoparticles in all assays was higher than the free drug and was found to increase in a dose dependent manner. A nanocarrier based delivery system of meloxicam potentiates its free radical suppression effects and can further enhance its therapeutic efficacy in the management of rheumatoid arthritis.

참고문헌 (Reference)

1 Frey O, "The role of regulatory T cells in antigen-induced arthritis: aggravation of arthritis after depletion and amelioration after transfer of CD4 ? CD25 ? T cells" 7 : R291-R301, 2005

2 Chan P, "The in vitro antioxidant activity of trilinolein and other lipid-related natural substances as measured by enhanced chemiluminescence" 59 (59): 2067-2073, 1996

3 Quan L, "The development of novel therapies for rheumatoid arthritis" 18 (18): 723-738, 2008

4 Halliwell B, "The deoxyribose method: a sample test tube assay for determination of rate constant for reaction of hydroxyl radicals" 165 : 215-219, 1987

5 Han-Moe Ki, "The Effect of Meloxicam/Ethanolamine Salt Formation on Percutaneous Absorption of Meloxicam" 대한약학회 30 (30): 215-221, 2007

6 Tanaka A, "Protection by constitutively formed nitric oxide of intestinal damage induced by indomethacin in rats" 95 : 35-41, 2001

7 Ali H, "Preparation and in vitro antiproliferative effect of tocotrienol loaded lipid nanoparticles" 353 : 43-51, 2010

8 Mira EG, "Potential use of nanostructured lipid carriers for topical delivery of flurbiprofen" 100 (100): 242-250, 2011

9 Desai PB, "Oxidative stress and enzymatic antioxidant status in rheumatoid arthritis: a case control study" 14 : 959-967, 2010

10 Hitchon CA, "Oxidation in rheumatoid arthritis" 6 : 265-278, 2004

11 Pham CTN, "Nanotherapeutic approaches for the treatment of rheumatoid arthritis" 3 : 607-619, 2011

12 Joshi M, "Nanostructured lipid carrier (NLC) based gel of celecoxib" 346 : 124-132, 2008

13 Kyung-Hyun Cho, "Monoacylglycerol (MAG)-Oleic Acid Has Stronger Antioxidant, Anti-Atherosclerotic, and Protein Glycation Inhibitory Activities than MAG-Palmitic Acid" 한국식품영양과학회 13 (13): 99-107, 2010

14 Agha AM, "Modulation of oxidant status by meloxicam in experimentally induced arthritis" 40 (40): 385-392, 1999

15 Hofkens W, "Liposomal targeting of glucocorticoids to the inflamed synovium inhibits cartilage matrix destruction during murine antigen induced arthritis" 416 (416): 486-492, 2011

16 Hoven JM, "Liposomal drug formulations in the treatment of rheumatoid arthritis" 8 : 1002-1015, 2011

17 Ambrus R, "Investigation of preparation parameters to improve the dissolution of poorly water-soluble meloxicam" 381 : 153-159, 2009

18 Anandjiwala SH, "Free radical scavenging activity of Bergia suffruticosa (Delile) Fenzl" 61 : 59-62, 2007

19 Elnaggar YSR, "Fabrication, appraisal, and transdermal permeation of sildenafil citrate-loaded nanostructured lipid carriers versus solid lipid nanoparticles" 6 : 3195-3205, 2011

20 Verma N, "Evaluation of inhibitory activities of plant extracts on production of LPSstimulated pro-inflammatory mediators in J774 murine macrophages" 336 (336): 127-135, 2010

21 Unni MK, "Evaluation of antioxidant properties of berries" 19 : 103-110, 2004

22 Firestein GS, "Etiology and pathogenesis of rheumatoid arthritis, In Kelley’s textbook of rheumatology" Elsevier Saunders 996-1042, 2005

23 Kim SY, "Effect of heating conditions of grape seeds on the antioxidant activity of grape seed extracts" 97 : 472-479, 2006

24 Shaji J, "Development and validation of a reverse phase-HPLC method for determination of meloxicam in pharmaceutical dosage forms and human plasma" 12 (12): 152-160, 2012

25 Hao J, "Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box–Behnken design" 6 : 683-692, 2011

26 Samir Mitragotri, "Designing Micro- and Nano-particles for Treating Rheumatoid Arthritis" 대한약학회 34 (34): 1887-1897, 2011

27 Turini ME, "Cyclooxygenase-2: a therapeutic target" 53 : 35-57, 2002

28 Dannhardt G, "Cyclooxygenase inhibitors-current status and future prospects" 36 : 109-126, 2001

29 Freitas C, "Correlation between long-term stability of solid lipid nanoparticles (SLN) and crystallinity of the lipid phase" 47 (47): 125-132, 1999

30 Nagy G, "Central role of nitric oxide in the pathogenesis of rheumatoid arthritis and systemic lupus erythematosus" 12 (12): 210-, 2010

31 Mai W, "Antioxidant activity of Rhizoma Cibotii in vitro" 2 (2): 107-114, 2012

32 Ah YC, "A novel transdermal patch incorporating meloxicam: in vitro and in vivo characterization" 385 : 12-19, 2010